| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |